Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has issued an announcement.
Recordati has provided an update on its share buyback program, initiated on 30 April 2025, which aims to purchase shares for stock option and performance share plans. From 15 to 19 September 2025, Recordati purchased 108,016 ordinary shares, with a weighted average price of €53.1151 per share, bringing its total holdings to 4,342,104 shares, or 2.076% of the share capital. This move is part of Recordati’s strategy to enhance its financial structure and incentivize management, potentially impacting its market positioning positively.
The most recent analyst rating on (IT:REC) stock is a Hold with a EUR57.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange. Founded in the 1920s from a family-run pharmacy in Northern Italy, the company now offers therapeutic options in both general and specialist medicine segments, as well as rare diseases. Recordati operates in a fully integrated manner, covering clinical development, production, marketing, and licensing of active ingredients and finished products. The company is present in about 150 countries across the EMEA, Americas, and APAC regions, employing over 4,580 people worldwide.
Average Trading Volume: 231,482
Technical Sentiment Signal: Buy
Current Market Cap: €10.91B
Find detailed analytics on REC stock on TipRanks’ Stock Analysis page.